{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:55:33Z","timestamp":1782856533878,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS KAKENHI","doi-asserted-by":"publisher","award":["15H04873"],"award-info":[{"award-number":["15H04873"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19ek0109228h0003"],"award-info":[{"award-number":["19ek0109228h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm Regener"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Among the different etiologies for fever of unknown origin in children, infectious diseases are the most frequent final diagnosis, followed by autoimmune diseases and malignancies. Autoinflammatory diseases are relatively rare among children and are frequently overlooked as differential diagnoses for fever of unknown origin. Once the possibility of a particular autoimmune disease is considered by physicians, the diagnosis might be easily made by a genetic approach because many of autoinflammatory diseases are of monogenic origin. To reach the diagnosis, detailed history-taking, precise physical examinations, and cytokine profiling as well as extensive mutation analysis of candidate genes should be undertaken for febrile children. Such the approach will protect the patients, and their family to undergo \u201cdiagnostic odyssey\u201d in which unnecessary and sometimes risky diagnostic and therapeutic interventions are taken.<\/jats:p><jats:p>This short review discusses the clinical and laboratory features of familial Mediterranean fever and systemic juvenile idiopathic arthritis, as representative illnesses of monogenic and polygenic autoinflammatory diseases, respectively. Cytokine profiling and mutation analyses both help to understand and decipher the heterogeneous pathologies in both disease categories.<\/jats:p>","DOI":"10.1186\/s41232-022-00204-y","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T03:28:22Z","timestamp":1656732502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical perspectives and therapeutic strategies: pediatric autoinflammatory disease\u2014a multi-faceted approach to fever of unknown origin of childhood"],"prefix":"10.1186","volume":"42","author":[{"given":"Akihiro","family":"Yachie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,2]]},"reference":[{"key":"204_CR1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jmii.2015.08.007","volume":"50","author":"Y-L Chien","year":"2017","unstructured":"Chien Y-L, Huang F-L, Huang C-M, Chen P-Y. Clinical approach to fever of unknown origin in children. J Microbiol Immunol Infect. 2017;50:893\u20138.","journal-title":"J Microbiol Immunol Infect"},{"key":"204_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","volume":"97","author":"MF McDermott","year":"1999","unstructured":"McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133\u201344.","journal-title":"Cell."},{"key":"204_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","volume":"140","author":"DL Kastner","year":"2010","unstructured":"Kastner DL, Aksentijevich I, Goldbach-Mansky R. Autoinflammatory disease reloaded: a clinical perspective. Cell. 2010;140:784\u201390.","journal-title":"Cell."},{"key":"204_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/00005792-199807000-00005","volume":"77","author":"J Samuels","year":"1998","unstructured":"Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore). 1998;77:268\u201397.","journal-title":"Medicine (Baltimore)"},{"key":"204_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/cge.12654","volume":"89","author":"SL Sawyer","year":"2016","unstructured":"Sawyer SL, Hartley T, Dyment DA, Beaulieu CL, Schwartzentruber J, Smith A, et al. Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care. Clin Genet. 2016;89:275\u201384.","journal-title":"Clin Genet"},{"key":"204_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","volume":"40","author":"SG Tangye","year":"2020","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2020;40:24\u201364.","journal-title":"J Clin Immunol"},{"key":"204_CR7","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1042\/CS20171498","volume":"132","author":"F Moghaddas","year":"2018","unstructured":"Moghaddas F, Masters SL. The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders. Clin Sci. 2018;132:1901\u201324.","journal-title":"Clin Sci"},{"key":"204_CR8","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00431-017-2991-z","volume":"176","author":"JI Hoell","year":"2017","unstructured":"Hoell JI, Warfsmann J, Gagnon G, Trocan L, Balzer S, Oommen PT, et al. Palliative care for children with a yet undiagnosed syndrome. Eur J Pediatr. 2017;176:1319\u201327.","journal-title":"Eur J Pediatr"},{"key":"204_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13023-018-0902-7","volume":"13","author":"JS Hausmann","year":"2018","unstructured":"Hausmann JS, Lomax KG, Shapiro A, Durrant K. The patient journey to diagnosis and treatment of autoinflammatory diseases. Orphanet J Rare Dis. 2018;13:156.","journal-title":"Orphanet J Rare Dis"},{"key":"204_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12519-011-0240-5","volume":"7","author":"A Chow","year":"2011","unstructured":"Chow A, Robinson JL. Fever of unknown origin in children: a systematic review. World J Pediatr. 2011;7:5\u201310.","journal-title":"World J Pediatr"},{"key":"204_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jmii.2015.01.001","volume":"50","author":"C-Y Cho","year":"2017","unstructured":"Cho C-Y, Lai C-C, Lee M-L, Hsu C-L, Chen C-J, Chang L-Y, et al. Clinical analysis of fever of unknown origin in children: a 10-year experience in a northern Taiwan medical center. J Microbiol Immunol Infect. 2017;50:40\u20135.","journal-title":"J Microbiol Immunol Infect"},{"key":"204_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/08035250500437549","volume":"95","author":"S Pasic","year":"2006","unstructured":"Pasic S, Minic A, Djuric P, Micic D, Kuzmanovic M, Sarjanovic L, et al. Fever of unknown origin in 185 pediatric patients: a single-centre experience. Acta Paediatr. 2006;95:463\u20136.","journal-title":"Acta Paediatr"},{"key":"204_CR13","doi-asserted-by":"crossref","unstructured":"Kim Y-S, Kim K-R, Kang J-M, Kim J-M, Kim Y-J.\u00a0Etiology and clinical characteristics of fever of unknown origin in children: a 15-year experience in a single center. Korean J Pediatr. 2017;60:77\u201385.","DOI":"10.3345\/kjp.2017.60.3.77"},{"key":"204_CR14","doi-asserted-by":"publisher","first-page":"e032059","DOI":"10.1136\/bmjopen-2019-032059","volume":"9","author":"T Naito","year":"2019","unstructured":"Naito T, Tanei M, Ikeda N, Ishii T, Suzuki T, Morita H, et al. Key diagnostic characteristics of fever of unknown origin in Japanese patients: a prospective multicentre study. BMJ Open. 2019;9:e032059.","journal-title":"BMJ Open"},{"key":"204_CR15","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.2169\/internalmedicine.53.2218","volume":"53","author":"M Yamanouchi","year":"2014","unstructured":"Yamanouchi M, Uehara Y, Yokokawa H, Hosoda T, Watanabe Y, Shiga T, et al. Analysis of 256 cases of classic fever of unknown origin. Intern Med. 2014;53:2471\u20135.","journal-title":"Intern Med"},{"key":"204_CR16","first-page":"5862","volume":"7","author":"K-K Yu","year":"2014","unstructured":"Yu K-K, Chen S-S, Ling Q-X, Huang C, Zheng J-M, Li N, et al. Fever of unknown origin: report of 107 cases in a university hospital. Int J Clin Exp Med. 2014;7:5862\u20136.","journal-title":"Int J Clin Exp Med"},{"key":"204_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.7861\/clinmedicine.15-3-295","volume":"15","author":"HJ Lachmann","year":"2015","unstructured":"Lachmann HJ. Autoinflammatory syndromes as causes of fever of unknown origin. Clin Med. 2015;15:295\u20138.","journal-title":"Clin Med"},{"key":"204_CR18","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006;3:e297.","journal-title":"PLoS Med"},{"key":"204_CR19","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.lpm.2018.12.003","volume":"48","author":"S Georgin-Lavialle","year":"2019","unstructured":"Georgin-Lavialle S, Fayand A, Rodrigues F, Bachmeyer C, Savey L, Grateau G. Autoinflammatory diseases: state of the art. Presse Med. 2019;48:e25\u201348.","journal-title":"Presse Med"},{"key":"204_CR20","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.lpm.2018.08.014","volume":"48","author":"H Ozdogan","year":"2019","unstructured":"Ozdogan H, Ugurlu S. Familial Mediterranean fever. Presse Med. 2019;48:e61\u201376.","journal-title":"Presse Med"},{"key":"204_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng0997-25","volume":"17","author":"French FMF Consortium","year":"1997","unstructured":"French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25\u201331.","journal-title":"Nat Genet"},{"key":"204_CR22","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","volume":"90","author":"International FMF Consortium","year":"1997","unstructured":"International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797\u2013807.","journal-title":"Cell."},{"key":"204_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gene.2017.05.013","volume":"626","author":"N Cekin","year":"2017","unstructured":"Cekin N, Akyurek ME, Pinarbasi E, Ozen F. MEFV mutations and their relation to major clinical symptoms of familial Mediterranean fever. Gene. 2017;626:9\u201313.","journal-title":"Gene."},{"key":"204_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s13075-014-0439-7","volume":"16","author":"D Kishida","year":"2014","unstructured":"Kishida D, Nakamura A, Yazaki M, Tsuchiya-Suzuki A, Matsuda M, Ikeda S. Genotype-phenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations. Arthritis Res Ther. 2014;16:439.","journal-title":"Arthritis Res Ther"},{"key":"204_CR25","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1136\/ard.2009.113415","volume":"69","author":"JG Ryan","year":"2010","unstructured":"Ryan JG, Masters SL, Booty MG, Habal N, Alexander JD, Barham BK, et al. Clinical features and functional significance of the P369S\/R408Q variant in pyrin, the familial Mediterranean fever protein. Ann Rheum Dis. 2010;69:1383\u20138.","journal-title":"Ann Rheum Dis"},{"key":"204_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/13497413.2018.1481579","volume":"41","author":"K Migita","year":"2018","unstructured":"Migita K, Asano T, Sata S, Koga T, Fujita Y, Kawakami A. Familial Mediterranean fever: overview of pathogenesis, clinical features and management. Immunol Med. 2018;41:55\u201361.","journal-title":"Immunol Med"},{"key":"204_CR27","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jpeds.2009.12.010","volume":"156","author":"S Padeh","year":"2010","unstructured":"Padeh S, Livneh A, Pras E, Shinar Y, Lidar M, Feld O, et al. Familial Mediterranean fever in the first two years of life: a unique phenotype of the disease evolution. J Pediatr. 2010;156:985\u20139.","journal-title":"J Pediatr"},{"key":"204_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00296-018-4123-0","volume":"39","author":"HE S\u00f6nmez","year":"2019","unstructured":"S\u00f6nmez HE, Esmeray P, Batu ES, Arici ZS, Demir S, Sa\u011f E, et al. Is age associated with disease severity and compliance to treatment in children with familial Mediterranean fever? Rheumatol Int. 2019;39:83\u20137.","journal-title":"Rheumatol Int"},{"key":"204_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/14397595.2018.1500874","volume":"29","author":"E \u00c7elikel","year":"2019","unstructured":"\u00c7elikel E, \u00d6z\u00e7akar ZB, \u00d6zdel S, \u00c7akar N, Aydin F, \u015eahin S, et al. Neonatal onset familial Mediterranean fever. Mod Rheumatol. 2019;29:647\u201350.","journal-title":"Mod Rheumatol"},{"key":"204_CR30","doi-asserted-by":"crossref","unstructured":"Tanatar A, Karada\u011f \u015eG, \u00c7akan M, S\u00f6nmez HE, Ayaz NA. Age of onset as an influencing factor for disease severity in children with familial Mediterranean fever. Mod Rheumatol.\u00a02021;31:219\u201322.","DOI":"10.1080\/14397595.2020.1719594"},{"key":"204_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/MD.0b013e318277cf75","volume":"91","author":"K Migita","year":"2012","unstructured":"Migita K, Uehara R, Nakamura Y, Yasunami M, Tsuchiya-Suzuki A, Yazaki M, et al. Familial Mediterranean fever in Japan. Medicine. 2012;91:337\u201343.","journal-title":"Medicine"},{"key":"204_CR32","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/14397595.2019.1621440","volume":"30","author":"D Kishida","year":"2020","unstructured":"Kishida D, Yazaki M, Nakamura A, Tsuchiya-Suzuki A, Shimojima Y, Sekijima Y. Late-onset familial Mediterranean fever in Japan. Mod Rheumatol. 2020;30:564\u20137.","journal-title":"Mod Rheumatol"},{"key":"204_CR33","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","volume":"49","author":"M Shimizu","year":"2010","unstructured":"Shimizu M, Yokoyama T, Yamada K, Kaneda H, Wada H, Wada T, et al. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology. 2010;49:1645\u201353.","journal-title":"Rheumatology"},{"key":"204_CR34","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1002\/pbc.24480","volume":"60","author":"T Wada","year":"2013","unstructured":"Wada T, Muraoka M, Yokoyama T, Toma T, Kanegane H, Yachie A. Cytokine profiles in children with primary Epstein-Barr virus infection. Pediatr Blood Cancer. 2013;60:e46\u20138.","journal-title":"Pediatr Blood Cancer"},{"key":"204_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cyto.2019.03.001","volume":"119","author":"A Jinkawa","year":"2019","unstructured":"Jinkawa A, Shimizu M, Nishida K, Kaneko S, Usami M, Sakumura N, et al. Cytokine profile of macrophage activation syndrome associated with Kawasaki disease. Cytokine. 2019;119:52\u20136.","journal-title":"Cytokine."},{"key":"204_CR36","doi-asserted-by":"publisher","first-page":"108252","DOI":"10.1016\/j.clim.2019.108252","volume":"208","author":"M Takakura","year":"2019","unstructured":"Takakura M, Shimizu M, Irabu H, Sakumura N, Inoue N, Mizuta M, et al. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Clin Immunol. 2019;208:108252.","journal-title":"Clin Immunol"},{"key":"204_CR37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/cei.13026","volume":"191","author":"M Shimizu","year":"2018","unstructured":"Shimizu M, Inoue N, Mizuta M, Nakagishi Y, Yachie A. Characteristic elevation of soluble TNF receptor II:I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis. Clin Exp Immunol. 2018;191:349\u201355.","journal-title":"Clin Exp Immunol"},{"key":"204_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cyto.2013.09.007","volume":"65","author":"T Wada","year":"2014","unstructured":"Wada T, Kanegane H, Ohta K, Katoh F, Imamura T, Nakazawa Y, et al. Sustained elevation of interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. Cytokine. 2014;65:74\u20138.","journal-title":"Cytokine."},{"key":"204_CR39","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ng.3089","volume":"46","author":"SW Canna","year":"2014","unstructured":"Canna SW, de Jesus AA, Gouni S, Brooks SR, Marrero B, Liu Y, et al. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014;46:1140\u20136.","journal-title":"Nat Genet"},{"key":"204_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3109\/14397595.2014.988861","volume":"26","author":"T Yamazaki","year":"2016","unstructured":"Yamazaki T, Shigemura T, Kobayashi N, Honda K, Yazaki M, Masumoto J, et al. IL-18 serum concentration is markedly elevated in typical familial Mediterranean fever with M694I mutation and can distinguish it from atypical type. Mod Rheumatol. 2016;26:315\u20137.","journal-title":"Mod Rheumatol"},{"key":"204_CR41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cyto.2017.10.007","volume":"104","author":"T Wada","year":"2018","unstructured":"Wada T, Toma T, Miyazawa H, Koizumi E, Shirahashi T, Matsuda Y, et al. Longitudinal analysis of serum interleukin-18 in patients with familial Mediterranean fever carrying MEFV mutation in exon 10. Cytokine. 2018;104:143\u20136.","journal-title":"Cytokine."},{"key":"204_CR42","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/annrheumdis-2012-202774","volume":"73","author":"A Omenetti","year":"2014","unstructured":"Omenetti A, Carta S, Delfino L, Martini A, Gattorno M, Rubartelli A. Increased NLRP3-dependent interleukin 1\u03b2 secretion in patients with familial Mediterranean fever: correlation with MEFV genotype. Ann Rheum Dis. 2014;73:462\u20139.","journal-title":"Ann Rheum Dis"},{"key":"204_CR43","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.humimm.2015.06.007","volume":"76","author":"A Repa","year":"2015","unstructured":"Repa A, Bertsias GK, Petraki E, Choulaki C, Vassou D, Kambas K, et al. Dysregulated production of interleukin-1\u03b2 upon activation of the NLRP3 inflammasome in patients with familial Mediterranean fever. Hum Immunol. 2015;76:488\u201395.","journal-title":"Hum Immunol"},{"key":"204_CR44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2017.00043","volume":"8","author":"C de Torre-Minguela","year":"2017","unstructured":"de Torre-Minguela C, Mesa Del Castillo P, Pelegr\u00edn P. The NLRP3 and pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases. Front Immunol. 2017;8:43.","journal-title":"Front Immunol"},{"key":"204_CR45","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/rheumatology\/keu359","volume":"54","author":"K Migita","year":"2015","unstructured":"Migita K, Izumi Y, Fujikawa K, Agematsu K, Masumoto J, Jiuchi Y, et al. Dysregulated mature IL-1\u03b2 production in familial Mediterranean fever. Rheumatology. 2015;54:660\u20135.","journal-title":"Rheumatology."},{"key":"204_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Dav\u00ec S, Horne A, Bovis F, Pistorio A, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European league against rheumatism\/American college of rheumatology\/paediatric rheumatology international trials organisation collaborative initiative. Ann Rheum Dis. 2016;75:481\u20139.","journal-title":"Ann Rheum Dis"},{"key":"204_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1546-0096-10-29","volume":"10","author":"AE Tebo","year":"2012","unstructured":"Tebo AE, Jaskowski T, Davis KW, Whiting A, Clifford B, Zeft A, et al. Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2012;10:29.","journal-title":"Pediatr Rheumatol Online J"},{"key":"204_CR48","doi-asserted-by":"crossref","unstructured":"Mizuta M, Shimizu M, Irabu H, Usami M, Inoue N, Nakagishi Y, et al. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children. Rheumatology. 2020; in press.","DOI":"10.1136\/annrheumdis-2019-eular.6898"},{"key":"204_CR49","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.berh.2018.02.002","volume":"31","author":"M Pardeo","year":"2017","unstructured":"Pardeo M, Bracaglia C, De Benedetti F. Systemic juvenile idiopathic arthritis: new insights into pathogenesis and cytokine directed therapies. Best Pract Res Clin Rheumatol. 2017;31:505\u201316.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"204_CR50","first-page":"150","volume":"45","author":"JR Silva","year":"2020","unstructured":"Silva JR, Brito I. Systemic juvenile idiopathic arthritis versus adult-onset Still\u00b4s disease: the pertinence of changing the current classification criteria. Acta Rheumatol Port. 2020;45:150\u20131.","journal-title":"Acta Rheumatol Port"},{"key":"204_CR51","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","volume":"169","author":"N Inoue","year":"2016","unstructured":"Inoue N, Shimizu M, Tsunoda S, Kawano M, Matsumura M, Yachie A. Cytokine profile in adult-onset Still\u2019s disease: comparison with systemic juvenile idiopathic arthritis. Clin Immunol. 2016;169:8\u201313.","journal-title":"Clin Immunol"},{"key":"204_CR52","doi-asserted-by":"publisher","first-page":"345-.8","DOI":"10.1016\/j.cyto.2012.11.025","volume":"61","author":"M Shimizu","year":"2013","unstructured":"Shimizu M, Nakagishi Y, Yachie A. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine. 2013;61:345-.8.","journal-title":"Cytokine."},{"key":"204_CR53","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12026-014-8561-9","volume":"61","author":"Y Jamilloux","year":"2015","unstructured":"Jamilloux Y, Gerfaud-Valentin M, Martinon F, Belot A, Henry T, S\u00e8ve P. Pathogenesis of adult-onset Still\u2019s disease: new insights from the juvenile counterpart. Immunol Res. 2015;61:53\u201362.","journal-title":"Immunol Res"},{"key":"204_CR54","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","volume":"13","author":"ATJ Maria","year":"2014","unstructured":"Maria ATJ, Le Quellec A, Jorgensen C, Touitou I, Rivi\u00e8re S, Guilpain P. Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions. Autoimmun Rev. 2014;13:1149\u201359.","journal-title":"Autoimmun Rev"},{"key":"204_CR55","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.3389\/fimmu.2019.03089","volume":"10","author":"J Vandenhaute","year":"2020","unstructured":"Vandenhaute J, Wouters CH, Matthys P. Natural killer cells in systemic autoinflammatory diseases: a focus on systemic juvenile idiopathic arthritis and macrophage activation syndrome. Front Immunol. 2020;10:3089.","journal-title":"Front Immunol"},{"key":"204_CR56","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/art.24750","volume":"60","author":"W de Jager","year":"2009","unstructured":"de Jager W, Vastert SJ, Beekman JM, Wulffraat NM, Kuis W, Coffer PJ, et al. Defective phosphorylation of interleukin-18 receptor \u03b2 causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009;60:2782\u201393.","journal-title":"Arthritis Rheum"},{"key":"204_CR57","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1016\/j.molimm.2010.05.290","volume":"47","author":"Y Huang","year":"2010","unstructured":"Huang Y, Lei Y, Zhang H, Dayton A. Role of interleukin-18 in human natural killer cell is associated with interleukin-2. Mol Immunol. 2010;47:2604\u201310.","journal-title":"Mol Immunol"},{"key":"204_CR58","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.4049\/jimmunol.162.10.5894","volume":"162","author":"W Walker","year":"1999","unstructured":"Walker W, Aste-Amezaga M, Kastelein RA, Trinchieri G, Hunter CA. IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma. J Immunol. 1999;162:5894\u2013901.","journal-title":"J Immunol"},{"key":"204_CR59","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/ar1453","volume":"7","author":"J Villanueva","year":"2005","unstructured":"Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A, et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther. 2005;7:R30\u20137.","journal-title":"Arthritis Res Ther"},{"key":"204_CR60","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/ped.13679","volume":"60","author":"M Takakura","year":"2018","unstructured":"Takakura M, Shimizu M, Yokoyama T, Mizuta M, Yachie A. Transient natural killer cell dysfunction associated with interleukin-18 overproduction in systemic juvenile idiopathic arthritis. Pediatr Int. 2018;60:984\u20135.","journal-title":"Pediatr Int"},{"key":"204_CR61","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","volume":"118","author":"MB Jordan","year":"2011","unstructured":"Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118:4041\u201352.","journal-title":"Blood"},{"key":"204_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fped.2016.00047","volume":"4","author":"E Ishii","year":"2016","unstructured":"Ishii E. Hemophagocytic lymphohistiocytosis in children: pathogenesis and treatment. Front Pediatr. 2016;4:47.","journal-title":"Front Pediatr"},{"key":"204_CR63","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","volume":"12","author":"AA Grom","year":"2016","unstructured":"Grom AA, Horne A, de Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016;12:259\u201368.","journal-title":"Nat Rev Rheumatol"},{"key":"204_CR64","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.semarthrit.2017.03.006","volume":"47","author":"S Ozen","year":"2017","unstructured":"Ozen S, Kone-Paut I, G\u00fcl A. Colchicine resistance and intolerance in familial Mediterranean fever: definition, causes, and alternative treatments. Semin Arthritis Rheum. 2017;47:115\u201320.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Inflammation and Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-022-00204-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41232-022-00204-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-022-00204-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T16:05:52Z","timestamp":1676045152000},"score":1,"resource":{"primary":{"URL":"https:\/\/inflammregen.biomedcentral.com\/articles\/10.1186\/s41232-022-00204-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,2]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["204"],"URL":"https:\/\/doi.org\/10.1186\/s41232-022-00204-y","relation":{},"ISSN":["1880-8190"],"issn-type":[{"value":"1880-8190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,2]]},"assertion":[{"value":"28 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Human Research Committee of Kanazawa University Graduate School of Medical Science, and informed consent was provided according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The author approved the submission of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares that he has no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}